Abstract
Objective
To investigate the proliferation effect and its pathway of activin A on Ovarian epithelial cancer cells line OVCAR-3.
Methods
OVCAR-3 cells were cultured in vitro and the membrane receptor ActR II was detected by immunohistochemical method. The OVCAR-3 cells were cultured with 10 ng/ml activin A for 7 d to observe the effects. Activin A at 5, 10, 15 and 20 ng/ml was used separately to treat the OVCAR-3 cancer cells for 24, 48 and 72 h in order to draw the growth proliferation rate curve measured by MTT method. The expression of protein bcl-2 was detected by western-blot. When OVCAR-3 cells were treated with 10 ng/ml activin A and 5 μg/ml DDP for 24, 48 and 72 h, cell apoptosis could be detected by electron microscopy and flow cytometry (FCM).
Results
Positive expression of ActR II was detected. We also found that the proliferation of OVCAR-3 reached to the climax on the 5th day of culture. The experiments showed that the cells treated with activin A increased quickly and grew faster than those in control group. Moreover, OVCAR-3 cells treated with activin A for 48 h proliferated significantly greater than those treated for 24 h or 72 h (P<0.01). bcl-2 protein expression increased expression in activin A treated group than in control group (P<0.05).
Conclusion
Activin A could increase the proliferation of OVCAR-3 cells which may be through bcl-2 anti-apoptosis pathway.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rao BR, Slotman BJ. Endocrine factors in common epithelial ovarian epithelial cancer [J]. Endocr Rev 1991; 12:14–26.
Vale W, Rivier C, Hsueh A, et al. Chemical and biological characterization of the inhibin family of protein hormones Recent Prog Horm Res 1988;44:1–34.
Welt CK, Lambert-Messerlian G, Zheng W, et al. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma [J]. J Clin Endocrinol Metab 1997; 82:3720–3727.
Ying SY. Inhibins activins and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone [J]. Endocr Rev 1988; 9:267–293.
Zhang Z, Zhao Y, Batres Y, et al. Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP [J]. Biochem Biophys Res Commun 1997;234:362–365.
Shikone T, Matzuk, MM, Perlas E, et al. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor [J]. Mol Endocrinol 1994; 8:983–995.
Mabuchi Y, Yamoto M, Minami S, et al. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells [J]. Oncol Rep 2006;16:373–379.
Chao DT, Korsmeyer ST. Bcl-2 family: regulators of cell death [J]. Annu Rev Immunol 1998;16:395–419.
Minn AJ, Swain RE, Ma A. Recent progress on the regulation of apoptosis by bcl-2 family members [J]. Adv Immunol 1998; 70:245–279.
Choi KC, Kang SK, Nathwani PS, et al. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE) [J]. Mol Cell Endocrinol 2001; 174:99–110.
Choi KC, Kang SK, Tai CJ, et al. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium [J]. J Clin Endocrinol Metab 2001; 86:2125–2135.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Xq., Ren, B. & Du, Zh. Effect of activin A on OVCAR-3 Ovarian epithelial cancer cells. Chin. J. Cancer Res. 20, 186–189 (2008). https://doi.org/10.1007/s11670-008-0186-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11670-008-0186-x